Related Experiment Video
Updated: May 19, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
A role for vimentin in Crohn disease
Paul Henderson1, David C Wilson, Jack Satsangi
1Department of Child Life and Health, University of Edinburgh, Edinburgh, UK.
Autophagy
|August 30, 2012
Summary
Crohn disease involves genetics, environment, and immune responses. Vimentin (VIM) is a novel protein interacting with NOD2, regulating inflammatory signaling, autophagy, and bacterial handling in Crohn disease.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Crohn disease (CD) is a chronic inflammatory bowel disease with complex etiology.
- Genetic studies implicate innate immunity (NOD2), adaptive immunity (IL23R, ICOSLG), and autophagy (ATG16L1, IRGM) in CD pathogenesis.
- Adherent-invasive E. coli (AIEC) strains are implicated in CD, highlighting the role of gut microbiota.
Purpose of the Study:
- To identify novel proteins interacting with NOD2, a key susceptibility gene in Crohn disease.
- To investigate the functional role of Vimentin (VIM) in regulating NOD2-mediated inflammatory pathways.
Main Methods:
- Protein-protein interaction studies to identify VIM as a NOD2 interacting protein.
- Analysis of VIM's role in NOD2 signaling, including NF-κB activation.
- Assessment of VIM's impact on autophagy and bacterial handling in the context of NOD2 function.
Main Results:
- Vimentin (VIM) was identified as a novel interacting protein of NOD2.
- VIM regulates NOD2-mediated inflammatory NF-κB signaling.
- VIM influences NOD2-associated autophagy and bacterial handling processes.
Conclusions:
- Vimentin is a novel regulator of NOD2 activity in Crohn disease.
- Targeting the VIM-NOD2 interaction may offer new therapeutic strategies for CD.
- Understanding VIM's role provides insights into innate immune responses to gut microbiota in CD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...